FDA Approves Updated COVID Shots Amid Summer Surge
#FDA #CovidVaccinesFDA approved updated Covid vaccines targeting dominant XFG variant, with Pfizer shipping immediately. Shots cover high-risk groups, while availability questions remain amid federal policy shifts. Vaccines remain safe, preventing severe illness. read more
Trump Picks Surgeon Heidi Overton to Lead FDA
#FDA #PublicHealthTrump nominates Dr. Heidi Overton, a White House policy advisor and surgeon, to lead the FDA. Her vaccine and abortion stances draw scrutiny, though Senate confirmation remains uncertain amid bipartisan concerns. read more
Trump Nominates Abortion Foe to Lead FDA
#FDA #AbortionRightsTrump nominates Dr. Heidi Overton to lead the FDA; she advocates restricting abortion medication access and called Roe's reversal "a victory for life," sparking debate over her health policy influence. read more
Trump taps Heidi Overton to lead FDA
#FDA #TrumpAdministrationTrump picks Dr. Heidi Overton to lead the FDA, a trusted White House aide championing his health goals. She faces challenges balancing anti-regulatory, anti-corporate, and MAHA priorities while managing unfinished vaccine, drug, and food safety issues. read more
FDA Inspects Mexico Plant Amid Deadly Cyclospora Outbreak
#FDA #CyclosporaOutbreakFDA officials finally inspected Taylor Farms' Mexico facility linked to a cyclospora outbreak causing explosive diarrhea, but experts say the visit came too late, risking lost evidence amid nearly 14,000 cases and two deaths. read more
FDA proposes mandatory food additive safety notifications
#FDA #FoodSafetyFDA proposes mandatory safety notifications for new food ingredients, closing a GRAS loophole, and finalizes an ultraprocessed food definition. Impacts remain limited without congressional action. read more
FDA Panel Backs Peptides, Legal Access Still Uncertain
#Peptides #FDAFDA panel backed seven peptides despite safety concerns, but availability remains uncertain. Compounding pharmacies may gain approval via Category One list, though timelines vary. Demand outpaces evidence, and prescriptions would require pharmacies to prepare them. read more
FDA Faces Pivotal Decision on First mRNA Flu Shot
#mRNA #FDAFDA weighs Moderna's mRNA flu shot amid RFK Jr.'s scrutiny, after a February rejection and reversal. Approval could boost mRNA research, but funding cuts and industry fears chill innovation, impacting patients like a cancer survivor. read more
Ex-FDA chief calls Taylor Farms White House outreach unusual
#LettuceRecall #FDAFormer FDA chief Scott Gottlieb called Taylor Farms' White House contact to delay a lettuce recall "unusual" and not standard procedure, contrasting it with his own outbreak experience. The cyclospora outbreak has sickened thousands. read more
FDA Weighs Peptide Access Amid Kennedy Push and Scientist Warnings
#FDA #PeptidesThe FDA may approve unproven peptide injections pushed by Health Secretary RFK Jr., who says he uses them. Scientists warn of lacking evidence and safety data. An advisory committee meets Thursday to decide on seven peptides previously banned. read more
FDA panel weighs lifting peptide therapy restrictions
#FDA #PeptidesAn FDA advisory panel reviews seven popular peptides like TB-500 and BPC-157 for compounding pharmacy access, despite lacking large-scale human trials. Proponents cite benefits for recovery and metabolism, while scientists warn of limited data and safety risks. read more
FDA panel weighs regulation of unproven peptide therapies
#FDA #PeptideRegulationThe FDA convenes experts this week to decide if compounding pharmacies can produce popular but unproven injectable peptides like TB-500 and BPC-157. Advocates cite grey market risks, while scientists warn of sparse human evidence and potential safety dangers. read more
FDA retracts lettuce warning in cyclosporiasis outbreak
#FDA #CyclosporiasisThe FDA retracted its claim linking a cyclosporiasis outbreak to Taylor Farms lettuce, citing a false positive. Over 7,000 cases nationwide cause explosive diarrhea, with health officials struggling to identify the source amid staffing cuts and rising infections. read more
FDA panel to decide fate of popular peptide therapies
#PeptideTherapies #FDAFederal regulators may allow compounding pharmacies to produce popular peptides lacking FDA approval. Doctors cite insufficient data, while proponents argue access ensures safety. An FDA panel will decide on seven peptides, balancing risks against unproven benefits. read more
FDA panel endorses Moderna mRNA flu vaccine
#FDA #mRNAVaccineFDA advisory committee unanimously recommended Moderna's mRNA flu vaccine for adults 50+, marking its first new vaccine review since 2023. The vaccine offers potentially stronger, faster-adaptable protection against flu strains. read more
FDA Warns of Kidney Risk From Weight Loss Pill Alli
#FDA #WeightLossPillThe FDA warns that the weight loss pill Alli may cause rare kidney complications, urging those with kidney disease to consult a doctor. Twelve cases were identified, with symptoms including pain and swelling. GSK spun off the product to Haleon. read more
FDA launches review of abortion pill mifepristone safety
#AbortionPill #FDAFDA plans a politically charged safety review of mifepristone, despite 25 years of safe use by over 7.5 million women. Critics call it a politically motivated attack on science, while anti-abortion groups push for restrictions. read more
Trump moves to oust FDA chief over abortion pill
#AbortionPolitics #FDAPresident Trump approved removing FDA head Makary after anti-abortion groups criticized his handling of mifepristone access and drug approvals. Makary also clashed over vaccine policies and vape bans. The ouster leaves another health agency leaderless amid ongoing political battles. read more
FDA approves four flavored vapes after Trump pressure
#FDA #VapingFDA approved four flavored vapes from Glas after Trump pressured for faster action. Two menthol and two fruit flavors gained approval with age-verification tech. Critics warn of youth risks, while supporters cite adult smoking cessation benefits. read more
Trump administration may ban electric shocks for autistic kids
#AutismRights #FDATrump's administration may finally ban electrical shock devices for autistic children, reversing a delayed FDA rule. Experts warn these devices cause trauma, burns, and worsened behavior, labeling the practice as torture. A decision is expected soon. read more
FDA Vaccine Chief Ousted Again Amid Industry Clashes
#FDA #VaccinePolicyFDA vaccine chief Dr. Vinay Prasad is departing in April, his second ouster in a year. His tenure was marked by controversy over drug and vaccine review decisions, balancing faster approvals with stricter safety demands. read more
FDA Axes Autism Cure Warnings as Kennedy Appoints Skeptics
#FDA #AutismCuresFDA removed its webpage warning against unproven autism cures. Simultaneously, HHS Secretary RFK Jr. appointed individuals who have promoted such treatments to a key autism advisory committee, raising concerns about misinformation and policy shifts. read more
FDA Rejects Moderna Flu Shot Amid Political Interference Claims
#FDA #VaccinePolicyThe FDA rejected Moderna's mRNA flu vaccine application, citing trial design flaws. Experts allege the move is politically motivated and part of an anti-vaccine agenda, which could chill future vaccine development and public health innovation. read more
Lawmaker Questions FDAs Secretive Fast-Track Drug Program
#FDA #DrugSafetyA Democratic lawmaker raises concerns over an FDA program that expedites drug reviews, citing secrecy and potential ethics violations. He questions its legality and transparency, as agency staff debate the shift of decision-making from scientists. read more
FDA Official Resigns Over Anti-Vaccine Influence: Truth Vs Misinformation
#FDA #VaccinationSafetyDr. Peter Marks, the top vaccine official at the FDA, resigns, criticizing government health officials for allowing misinformation about vaccinations. RFK Jr. accused of promoting lies. The resignation fuels concerns about the impact on public health and vaccine safety. read more
FDA Official Resigns Amid Measles Outbreak Over Vaccine Misinformation
#FDA #VaccineMisinformationDr. Peter Marks, a top FDA official, resigned, criticizing Robert F Kennedy Jr's vaccine misinformation. Marks led efforts like Operation Warp Speed during COVID-19. Kennedy, a vaccine skeptic, claims he's not anti-vaccine. Marks highlighted the importance of vaccines like measles to prevent devastating outcomes. read more
Dr. Marty Makary Nominated by Trump to Lead FDA
#FDA #COVIDDr. Marty Makary, known for criticizing the medical establishment and COVID-19 response, is Trump's pick to lead the FDA. With fiery views aligning with Robert F. Kennedy Jr., his controversial stances on food, vaccines, and health issues raise concerns about his leadership. -19 read more
FDA Cancels Crucial Meeting Amid Worst Flu Season Fears
#FDA #FluVaccineMeetingThe FDA canceled an annual meeting to plan future flu vaccines amid this year's severe flu season. Concerns arise regarding U.S. preparedness. The decision impacts vaccine production timelines and follows the CDC halting a past flu vaccine campaign. read more
FDA Rehires Fired Employees Amid Confusion Over Musk's Cuts
#FDA #DOGEcutsAround 300 FDA employees, including scientists reviewing Musk's Neuralink, were fired and then rehired after Musk's DOGE cuts. Some FDA roles are funded by medical device companies. DOGE also fired and rehired nuclear specialists who oversee America's nuclear weapons in a cost-cutting move. read more
"FDA Scientists Ordered to Avoid Words like 'Transgender' and 'Disabled'"
#FDA #BannedWordsFDA scientists at a US federal health agency were instructed to avoid using terms like "woman," "disabled," and "elderly" in external communications, in compliance with Trump's executive order. The list of banned words has caused confusion among scientists, hindering their ability to address diverse medical needs. read more
Judge Orders Restoration of Public Health Info on Federal Websites
#FDA #CDCerrorMsgA federal judge ordered the Department of Health and Human Services, CDC, and FDA to reinstate vital public health information removed due to Trump's executive order attacking diversity. Doctors expressed concerns over patient care. . read more
FDA approves non-opioid pain medication Journavx, a breakthrough solution.
#FDA #PainMedicationThe FDA has approved Journavx, a new non-opioid pain medication, the first of its kind in two decades to reduce addiction risks. The drug, designed for short-term pain relief, is more expensive than opioids and shows modest effectiveness. read more
FDA bans red dye No. 3 over cancer concerns in food
#FDA #RedDyeBanThe FDA has banned red dye No. 3 from food, drinks, and drugs due to potential cancer risks, giving manufacturers until 2027 to remove it. This synthetic color additive had been permitted in certain products despite previous concerns about its safety. read more
FDA Issues Oyster Recall Over Norovirus Contamination Risk
#FDA #norovirusFDA issued a new oyster recall due to norovirus, advising against consumption of oysters from a specific area in Washington. Norovirus symptoms include diarrhea, cramps, and fever. Cases have surged recently. CDC recommends handwashing, proper cooking, and remaining home when sick. read more
Concerns Raised Over Potential Appointment of Vaccine Skeptic to Key Health Agency
#FDA #RFKJrFormer FDA leader during Trump’s term, Scott Gottlieb, expresses concerns over Robert F. Kennedy Jr. potentially leading a key health agency under the new administration. RFK Jr.'s anti-vaccine stance could lead to lower vaccination rates and a rise in preventable diseases. read more
RFK Jr. Warns FDA After Trump's Win, Calls for Changes
#FDA #Trump2024Robert F. Kennedy Jr. warned of major changes at the FDA after Donald Trump’s 2024 election win. Kennedy aims for a Cabinet position, criticizing food in the US compared to Canada. Trump supports Kennedy despite conspiracy concerns. read more
#FDA #InfantFormula
The FDA took 15 months to respond to a whistleblower complaint about conditions at an Abbott infant formula factory, impacting the 2022 nationwide formula shortage. The audit found inadequate procedures, delayed inspections, and the need for better reporting and policies. read more